Unrelated donor status and high donor age independently affect immunologic recovery after nonmyeloablative conditioning.

[1]  K. Weinberg,et al.  Immunological Reconstitution Following Hematopoietic Cell Transplantation , 2007 .

[2]  M. Maris,et al.  Unrelated donor granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell transplantation after nonmyeloablative conditioning: the effect of postgrafting mycophenolate mofetil dosing. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[3]  K. Weinberg,et al.  Immune reconstitution: from stem cells to lymphocytes. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[4]  R. Krance,et al.  Cytomegalovirus (CMV) infections and CMV-specific cellular immune reconstitution following reduced intensity conditioning allogeneic stem cell transplantation with Alemtuzumab , 2005, Bone Marrow Transplantation.

[5]  C. Carlo-Stella,et al.  Reduced-intensity conditioning containing low-dose alemtuzumab before allogeneic peripheral blood stem cell transplantation: graft-versus-host disease is decreased but T-cell reconstitution is delayed. , 2005, Experimental hematology.

[6]  S. Steinberg,et al.  Establishing a platform for immunotherapy: clinical outcome and study of immune reconstitution after high-dose chemotherapy with progenitor cell support in breast cancer patients. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[7]  A. Vallejo,et al.  The Influence of Age on T Cell Generation and TCR Diversity1 , 2005, The Journal of Immunology.

[8]  S. Heimfeld,et al.  High doses of transplanted CD34+ cells are associated with rapid T-cell engraftment and lessened risk of graft rejection, but not more graft-versus-host disease after nonmyeloablative conditioning and unrelated hematopoietic cell transplantation , 2005, Leukemia.

[9]  C. Mackall,et al.  Age-dependent incidence, time course, and consequences of thymic renewal in adults , 2005 .

[10]  J. Radich,et al.  HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with chronic myeloid leukemia. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[11]  M. Sorror,et al.  Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  K. Dietz,et al.  Onset of thymic recovery and plateau of thymic output are differentially regulated after stem cell transplantation in children. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[13]  J. Radich,et al.  Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning. , 2004, Blood.

[14]  D. Olive,et al.  Cytomegalovirus-specific immune recovery following allogeneic HLA-identical sibling transplantation with reduced-intensity preparative regimen , 2004, Bone Marrow Transplantation.

[15]  P. Linton,et al.  Age-related changes in lymphocyte development and function , 2004, Nature Immunology.

[16]  D. Follmann,et al.  Persisting posttransplantation cytomegalovirus antigenemia correlates with poor lymphocyte proliferation to cytomegalovirus antigen and predicts for increased late relapse and treatment failure. , 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[17]  C. Perreault,et al.  Evidence for adequate thymic function but impaired naive T-cell survival following allogeneic hematopoietic stem cell transplantation in the absence of chronic graft-versus-host disease. , 2003, Blood.

[18]  D. Maloney,et al.  Correlation between the numbers of naive T cells infused with blood stem cell allografts and the counts of naive T cells after transplantation. , 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[19]  F. Baron,et al.  T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantation , 2003, Transplantation.

[20]  M. Maris,et al.  Impact of unrelated donor status on the incidence and outcome of cytomegalovirus infections after non‐myeloablative allogeneic stem cell transplantation , 2003, British journal of haematology.

[21]  S. Riddell,et al.  Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: impact of host factors, drug therapy, and subclinical reactivation. , 2003, Blood.

[22]  M. Maris,et al.  Immunologic recovery after hematopoietic cell transplantation with nonmyeloablative conditioning. , 2003, Experimental hematology.

[23]  S. Mackinnon,et al.  T‐ and B‐cell immune reconstitution and clinical outcome in patients with multiple myeloma receiving T‐cell‐depleted, reduced‐intensity allogeneic stem cell transplantation with an alemtuzumab‐containing conditioning regimen followed by escalated donor lymphocyte infusions , 2003, British journal of haematology.

[24]  S. Heimfeld,et al.  HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies. , 2003, Blood.

[25]  D. Douek,et al.  Early reconstitution of the T‐cell repertoire after non‐myeloablative peripheral blood stem cell transplantation is from post‐thymic T‐cell expansion and is unaffected by graft‐versus‐host disease or mixed chimaerism , 2003, British journal of haematology.

[26]  W. Leisenring,et al.  Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity. , 2002, Blood.

[27]  D. Ho,et al.  Direct evidence for new T-cell generation by patients after either T-cell-depleted or unmodified allogeneic hematopoietic stem cell transplantations. , 2002, Blood.

[28]  M. Maris,et al.  Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study. , 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[29]  D. Douek,et al.  Factors influencing T-lymphopoiesis after allogeneic hematopoietic cell transplantation1 , 2002, Transplantation.

[30]  Andreas Radbruch,et al.  Two Subsets of Naive T Helper Cells with Distinct T Cell Receptor Excision Circle Content in Human Adult Peripheral Blood , 2002, The Journal of experimental medicine.

[31]  D. Douek,et al.  A broad T-cell repertoire diversity and an efficient thymic function indicate a favorable long-term immune reconstitution after cord blood stem cell transplantation. , 2002, Blood.

[32]  D. Neuberg,et al.  Quantitation of T-cell neogenesis in vivo after allogeneic bone marrow transplantation in adults. , 2001, Blood.

[33]  A. Nagler,et al.  Immune reconstitution following allogeneic stem cell transplantation in recipients conditioned by low intensity vs myeloablative regimen , 2001, Bone Marrow Transplantation.

[34]  D. Maloney,et al.  Factors influencing B lymphopoiesis after allogeneic hematopoietic cell transplantation. , 2001, Blood.

[35]  R. Storb,et al.  Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation. , 2001, Blood.

[36]  J. Radich,et al.  Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. , 2001, Blood.

[37]  Michihiro Kobayashi,et al.  The reconstitution of CD45RBhiCD4+ naive T cells is inversely correlated with donor age in murine allogeneic haematopoietic stem cell transplantation. , 2000 .

[38]  K. Atkinson.  Clinical bone marrow and blood stem cell transplantation , 2000 .

[39]  C. Perreault,et al.  The Effect of Graft-versus-Host Disease on T Cell Production and Homeostasis , 1999, The Journal of experimental medicine.

[40]  V. Calvez,et al.  Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease , 1998, The Lancet.

[41]  S. Riddell,et al.  Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis. , 1994, Blood.

[42]  S. Riddell,et al.  Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease. , 1991, Blood.

[43]  A. Globerson,et al.  In vitro analysis of age‐related changes in the developmental potential of bone marrow thymocyte progenitors , 1990, European journal of immunology.

[44]  C. Orosz,et al.  Enumeration of viral antigen-reactive helper T lymphocytes in human peripheral blood by limiting dilution for analysis of viral antigen-reactive T-cell pools in virus-seropositive and virus-seronegative individuals , 1989, Journal of clinical microbiology.

[45]  C. Taswell,et al.  Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. , 1981, Journal of immunology.

[46]  H. Ochs,et al.  Does graft-versus-host disease influence the tempo of immunologic recovery after allogeneic human marrow transplantation? An observation on 56 long-term survivors. , 1978, Blood.